These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2529506)

  • 1. [Chronic bone infections after surgery. Treatment with the new quinolones].
    Bricaire F; Godeau B; Salmon D; Karam D; Leport C; Vildé JL
    Presse Med; 1989 Sep; 18(28):1383-6. PubMed ID: 2529506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
    Dellamonica P; Bernard E; Etesse H; Garraffo R; Drugeon HB
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of efficacy and tolerability among 3 quinolones in the treatment of lower urinary tract infections (cinoxacin versus ciprofloxacin and pefloxacin].
    Sesia G; Cauda F; Alladio F
    Minerva Urol Nefrol; 1992; 44(3):217-8. PubMed ID: 1492275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
    Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
    Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New possibilities in the care of surgical infections (personal experience with pefloxacin)].
    Rakovec S; Stanisavljević D
    Acta Chir Iugosl; 1989; 36 Suppl 2():748-50. PubMed ID: 2618497
    [No Abstract]   [Full Text] [Related]  

  • 7. Pefloxacin in the treatment of gram-negative infections in patients with hematologic diseases.
    Micozzi A; Martino P; Raccah R; Girmenia C; Gentile G; Santilli S; Monarca B
    Haematologica; 1989; 74(6):583-5. PubMed ID: 2628241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of fluoroquinolones in rheumatology].
    Belov BS; Shubin SV; Nasonova VA; Soldatova SI; Tarasova GM; Urumova MM; Ushakova MA; Anan'eva LP
    Vestn Ross Akad Med Nauk; 1996; (12):12-5. PubMed ID: 9102072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis].
    Guibert J
    Presse Med; 1995 Feb; 24(6):304-8. PubMed ID: 7899391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pefloxacin in the treatment of severe infections in gynecological cancer patients.
    Scalambrino S; Colombo M; Negri L; Maggioni A; Milani R
    J Chemother; 1994 Aug; 6(4):257-64. PubMed ID: 7830104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of the new quinolones, ciprofloxacin and pefloxacin in experimental plague].
    Kasatkina IV; Sherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1993 Jan; 38(1):42-5. PubMed ID: 8060184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral pefloxacin in the treatment of CAPD peritonitis.
    Tan HW; Kon SP; Chua CT; Ngeow NF
    Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pefloxacin in the antibacterial treatment of immunodepressed patients.
    Cajozzo A; Carbone R; Carotenuto M; Grana M; La Sala A; Mancuso S; Perricone R; Sgalambro A; Dammacco F
    J Chemother; 1990 Jun; 2(3):185-9. PubMed ID: 2199629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
    Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
    Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
    Fong IW
    Clin Invest Med; 1989 Feb; 12(1):44-9. PubMed ID: 2646054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
    Mouton Y; Beuscart C; Leroy O; Pappo M; Drugeon H
    Presse Med; 1988 Oct; 17(37):1928-32. PubMed ID: 2973588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of salmonellosis and shigellosis with the new quinolones].
    Biron F; Boibieux A; Tigaud S; Peyramond D
    Pathol Biol (Paris); 1990 Nov; 38(9):894-8. PubMed ID: 2277722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with pefloxacin in patients with urinary tract infections.
    Chan PC; Cheng IK; Chan MK; Wong WT
    Br J Clin Pract; 1990 Dec; 44(12):564-7. PubMed ID: 2102145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
    Chidiac C; Senneville E; Mouton Y
    Pathol Biol (Paris); 1992 Jun; 40(6):638-45. PubMed ID: 1408383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pefloxacin treatment of meningitis caused by gram-negative bacteria.
    Segev S; Barzilai A; Rosen N; Joseph G; Rubinstein E
    Arch Intern Med; 1989 Jun; 149(6):1314-6. PubMed ID: 2730249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.